Indegene Limited, established in 1998, provides digital services to the life sciences industry. They help with drug development, clinical trials, regulatory filings, pharmacovigilance, complaint resolution, and sales/marketing support. DT Associates Limited, a subsidiary of the corporation, offers consulting services under the “DT Consulting” name. The organisation got the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, which was organised by Arogya World India Trust in collaboration with the Public Health Foundation of India.

The Indegene IPO GMP is a book-built issue for Rs 1,841.76 crore. The offering consists of a fresh issue of 1.68 crore shares for Rs 760.00 crores and an offer for sale of 2.39 crore shares for Rs 1,081.76 crores. Indegene IPO date begins on May 6, 2024 and ends on May 8, 2024. The allotment for the IPO is expected to be completed on Thursday, May 9, 2024. The Indegene IPO will list on the BSE and NSE, with a tentative listing date of Monday, May 13, 2024. The Indegene IPO GMP Today is ₹262.

The Indegene IPO price range is established at ₹430 to ₹452 per share. The minimum lot size for an application is 33 shares. Retail investors are needed to invest a minimum of ₹14,916. The minimum lot size investment for sNII is 14 lots (462 shares) worth ₹208,824, while for bNII, it is 68 lots (2,244 shares) for ₹1,014,288.